Product Launch


 

TIDMCRYO 
 
RNS Number : 3541M 
Cryo-Save Group NV 
21 May 2010 
 

21 May 2010 
 
Cryo-Save Group N.V. 
 
Launch of innovative Cryo-Lip  stem cell storage service for liposuction market 
 
Cryo-Save Group N.V. (Euronext/AIM: CRYO, "Cryo-Save" or "the Group"), Europe's 
leading stem cell bank, announces the European launch of Cryo-Lip , a new 
product that allows the collection, processing and storage of a rich mixture of 
adult stem cells from liposuction aspirate (fatty tissue that is normally 
discarded).  A new cryopreservation process for fatty tissue has been developed 
and submitted for international patent by Cryo-Save. 
 
Adult Stem Cells 
The primary roles of adult stem cells are to maintain and repair the tissue in 
which they are found. There are two main types: Hematopoietic Stem Cells (HSCs), 
forming all blood cells and Mesenchymal Stem Cells (MSCs), able to differentiate 
into multiple cell types such as bone, fat, muscle and cartilage. 
 
Fat or adipose tissue is an ideal source of adult stem cells: 
 
·      It is very rich in MSCs -  500 times the concentration found in bone 
marrow 
 
·      It is readily available, the 50ml needed for Cryo-Lip  can easily be 
obtained from liposuction procedures 
 
·      It is autologous, adult tissue, and hence has no ethical or immunological 
issues 
 
·      It is material that is normally discarded 
 
The Cryo-Lip  service (www.cryo-lip.com) will initially only be available in 
Europe and will be offered by qualified and trained physicians. The Group 
intends to market Cryo-Lip to plastic surgeons who are experienced in 
liposuction procedures and has already set up a partnership program for 
physicians. 
 
Clinical Applications 
The use of Adipose-derived Stem Cells (ASCs) is very promising, as testified by 
the exponential increase in both peer-reviewed medical publications and ongoing 
clinical trials. 
 
Professor Marco Gasparotti,pioneer of the superficial liposculpture technique 
commented: 
 
"I am pleased to join the Cryo-Lip  Advisory Panel as I believe that 
adipose-derived stem cells will play an important role in the future of both 
regenerative medicine and cosmetic surgery. The cryopreservation of such cells 
from liposuction waste material will further enhance the basis for future 
therapeutic advances". 
 
Arnoud van Tulder, Cryo-Save CEO, said: 
 
"The addition of the Cryo-Lip  service is an important advance for our company 
and allows us to leverage our market leadership position in the cryopreservation 
of adult stem cells". 
 
 
 
Website: www.cryo-lip.com 
 
Enquiries: 
 
+-------------------------------------+---------------------+ 
| Cryo-Save Group                     | +  31 (0)575 548998 | 
+-------------------------------------+---------------------+ 
| Arnoud van Tulder, Chief Executive  |                     | 
| Officer                             |                     | 
+-------------------------------------+---------------------+ 
| Henk Snyman, MD   General Manager   |                     | 
|                                     |                     | 
+-------------------------------------+---------------------+ 
| Daniel Stewart & Company plc        |     + 44 (0)20 7776 | 
|                                     |                6550 | 
+-------------------------------------+---------------------+ 
| Simon Leathers/Emma Earl            |                     | 
+-------------------------------------+---------------------+ 
|                                     |                     | 
+-------------------------------------+---------------------+ 
| College Hill (UK)                   |     + 44 (0)20 7457 | 
|                                     |                2020 | 
+-------------------------------------+---------------------+ 
| Adrian Duffield/Rozi Morris         |                     | 
+-------------------------------------+---------------------+ 
|                                     |                     | 
+-------------------------------------+---------------------+ 
| SPJ Financiële Communicatie Amstelveen (NL)               | 
| +31 (0)20 647 8181                                        | 
+-----------------------------------------------------------+ 
| Kees Jongsma/Léon Melens            |                     | 
+-------------------------------------+---------------------+ 
 
 
About Cryo-Save www.cryo-savegroup.com 
 
With more than 130,000 samples saved, Cryo-Save is the leading stem cell bank in 
Europe and one of the fastest growing in the world. Driven by its international 
business strategy, Cryo-Save is now represented in 38 countries on three 
continents and has state-of-the-art processing facilities in Belgium, Germany, 
Dubai, India and France (under construction). 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 PRLKKDDQDBKDBPB
Cryo-Save (LSE:CRYO)
過去株価チャート
から 12 2024 まで 1 2025